Anti-Cdk4 抗体
Anti-Cdk4 antibody
5
(1 Review)
|
(96 Publications)
Rabbit Polyclonal CDK4 antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 96 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CDK4 aa 100 to C-terminus.
別名を表示する
Cyclin-dependent kinase 4, Cell division protein kinase 4, PSK-J3, CDK4
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Cdk4 antibody (AB137675)
HeLa cells stained for CDK4 (green) using ab137675 at 1/500 dilution in ICC/IF.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Cdk4 antibody (AB137675)
MCF7 cells stained for CDK4 (green) using ab137675 at 1/1000 dilution in ICC/IF. Red staining of p21 Cip1 (a nucleus marker) at 1/500 dilution and Hoechst 33342 (blue) staining.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cdk4 antibody (AB137675)
Immunohistochemical analysis of paraffin-embedded Human gastric carcinoma tissue, labelling Cdk4 using ab137675 at 1/500 dilution.
- WB
AbReview58781****
Western blot - Anti-Cdk4 antibody (AB137675)
10% SDS-PAGE.
Blocked with 5% milk for 12 hours at 4°C.
Incubated with the primary antibody in 2% milk for 12 hours at 4°C.
All lanes:
Western blot - Anti-Cdk4 antibody (ab137675) at 1/1000 dilution
Lane 1:
Epithelial OVCAR whole cell lysate - untreated at 100 µg
Lane 2:
Epithelial OVCAR whole cell lysate treated with 100µM Perifosine for 24 hours at 100 µg
Lane 3:
Epithelial OVCAR whole cell lysate treated with 200µM Perifosine for 24 hours at 100 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/10000 dilution
Predicted band size: 34 kDa
Observed band size: 30 kDa
true
Exposure time: 5min
This image is courtesy of an anonymous Abreview.
- WB
Supplier Data
Western blot - Anti-Cdk4 antibody (AB137675)
12% SDS-PAGE
All lanes:
Western blot - Anti-Cdk4 antibody (ab137675) at 1/500 dilution
All lanes:
PC-12 whole cell extract at 30 µg
Predicted band size: 34 kDa
false
- WB
Supplier Data
Western blot - Anti-Cdk4 antibody (AB137675)
Samples were separated by 12% SDS-PAGE.
All lanes:
Western blot - Anti-Cdk4 antibody (ab137675) at 1/500 dilution
All lanes:
NIH-3T3 Whole cell extract at 30 µg
Secondary
All lanes:
HRP-conjugated anti-rabbit IgG antibody
Predicted band size: 34 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cdk4 plays a fundamental role in cell cycle regulation by forming a complex with D-type cyclins. Together they phosphorylate the retinoblastoma protein (Rb) resulting in the release of E2F transcription factors which promote the expression of genes necessary for DNA replication. The Cdk4/cyclin D complex regulates the cell's commitment to enter S phase and continue cell division. This regulation is key for normal cell proliferation and tissue homeostasis. Cdk4 activity is strictly controlled by INK4 family members acting as inhibitors and adding an extra regulation layer.
Pathways
Cdk4 is an integral part of important signaling pathways like the cell cycle and PI3K/AKT pathways. In the cell cycle pathway Cdk4 relays signals downstream that drive the transition from the G1 to S phase through its interaction with cyclin D and Rb. In the PI3K/AKT pathway signaling can influence cyclin D expression indirectly affecting Cdk4 activity. Proteins such as Cdk6 closely relate to Cdk4 and often compensate or partner with Cdk4 in these pathways to maintain proper cell cycle progression.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (96)
Recent publications for all applications. Explore the full list and refine your search
Experimental & molecular medicine 57:1996-2009 PubMed40887499
2025
Applications
Unspecified application
Species
Unspecified reactive species
Carcinogenesis 46: PubMed40823720
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 44:170 PubMed40462177
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 17: PubMed39796711
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell & bioscience 14:109 PubMed39210450
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell 187:1666-1684.e26 PubMed38490194
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 13:2323-2341 PubMed37424824
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:314 PubMed37160873
2023
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 180:2172-2188 PubMed36967633
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:112235 PubMed36920905
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com